- Home
- REXR vs ASND Comparison
REXR vs ASND Comparison
Compare REXR & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- ASND
- Stock Information
- Founded
- REXR 2013
- ASND 2006
- Country
- REXR United States
- ASND Denmark
- Employees
- REXR N/A
- ASND N/A
- Industry
- REXR Real Estate Investment Trusts
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- REXR Real Estate
- ASND Health Care
- Exchange
- REXR Nasdaq
- ASND Nasdaq
- Market Cap
- REXR 7.7B
- ASND 9.8B
- IPO Year
- REXR 2013
- ASND 2015
- Fundamental
- Price
- REXR $35.22
- ASND $162.84
- Analyst Decision
- REXR Hold
- ASND Strong Buy
- Analyst Count
- REXR 9
- ASND 16
- Target Price
- REXR $39.67
- ASND $213.88
- AVG Volume (30 Days)
- REXR 2.7M
- ASND 477.8K
- Earning Date
- REXR 07-16-2025
- ASND 05-01-2025
- Dividend Yield
- REXR 4.88%
- ASND N/A
- EPS Growth
- REXR 12.67
- ASND N/A
- EPS
- REXR 1.23
- ASND N/A
- Revenue
- REXR $974,598,000.00
- ASND $398,509,511.00
- Revenue This Year
- REXR $9.78
- ASND $76.03
- Revenue Next Year
- REXR $8.46
- ASND $74.19
- P/E Ratio
- REXR $28.67
- ASND N/A
- Revenue Growth
- REXR 18.04
- ASND 12.06
- 52 Week Low
- REXR $29.68
- ASND $111.09
- 52 Week High
- REXR $52.61
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- REXR 52.31
- ASND 53.99
- Support Level
- REXR $33.82
- ASND $156.56
- Resistance Level
- REXR $36.93
- ASND $163.55
- Average True Range (ATR)
- REXR 0.82
- ASND 6.04
- MACD
- REXR 0.12
- ASND 0.09
- Stochastic Oscillator
- REXR 45.02
- ASND 80.88
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.